Breast imaging software developer Densitas and cancer risk assessment and treatment management software developer CancerIQ are partnering to expand the functionality of Densitas’ AI-drive mammography quality assurance (QA) platform.
CancerIQ’s lifetime risk calculator will be integrated with Densitas’ QA platform, which includes IntelliMammo and IntelliMaven software. The calculator generates Tyrer-Cuzick and Gail scores and indicates how to comply with NCCN guidelines. It also supports the identification of high-risk patients.
The combined software will enable deeper, data-driven understanding of mammography quality and patient risk profiles, according to the companies.